Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 586

1.

Long-term remission and recurrence rates in Cushing's disease: predictive factors in a single-centre study.

Alexandraki KI, Kaltsas GA, Isidori AM, Storr HL, Afshar F, Sabin I, Akker SA, Chew SL, Drake WM, Monson JP, Besser GM, Grossman AB.

Eur J Endocrinol. 2013 Mar 20;168(4):639-48. doi: 10.1530/EJE-12-0921. Print 2013 Apr.

PMID:
23371975
2.

Long-term maintenance of normoglycaemia using everolimus in a patient with disseminated insulinoma and severe hypoglycaemia.

Thomas NJ, Brooke AM, Besser GM.

Clin Endocrinol (Oxf). 2013 May;78(5):799-800. doi: 10.1111/cen.12059. No abstract available.

PMID:
23082777
3.

Specific electrocardiographic features associated with Cushing's disease.

Alexandraki KI, Kaltsas GA, Vouliotis AI, Papaioannou TG, Trisk L, Zilos A, Korbonits M, Besser GM, Anastasakis A, Grossman AB.

Clin Endocrinol (Oxf). 2011 May;74(5):558-64. doi: 10.1111/j.1365-2265.2011.03975.x.

PMID:
21470280
4.

Comparisons in the epidemiology, diagnostic features and cure rate by transsphenoidal surgery between paediatric and adult-onset Cushing's disease.

Storr HL, Alexandraki KI, Martin L, Isidori AM, Kaltsas GA, Monson JP, Besser GM, Matson M, Evanson J, Afshar F, Sabin I, Savage MO, Grossman AB.

Eur J Endocrinol. 2011 May;164(5):667-74. doi: 10.1530/EJE-10-1120. Epub 2011 Feb 10.

PMID:
21310872
5.

AIP mutation in pituitary adenomas in the 18th century and today.

Chahal HS, Stals K, Unterländer M, Balding DJ, Thomas MG, Kumar AV, Besser GM, Atkinson AB, Morrison PJ, Howlett TA, Levy MJ, Orme SM, Akker SA, Abel RL, Grossman AB, Burger J, Ellard S, Korbonits M.

N Engl J Med. 2011 Jan 6;364(1):43-50. doi: 10.1056/NEJMoa1008020.

6.

No clear evidence for an association between GH replacement and relapse of intracranial germ cell tumours: single centre and KIMS experience.

Chung TT, Drake WM, Plowman PN, Metcalfe K, Grossman AB, Akker SA, Chew SL, Besser GM, Walker DM, Koltowska-Haggstrom M, Wilton P, Mattsson AF, Monson JP.

Eur J Endocrinol. 2010 Aug;163(2):357-8. doi: 10.1530/EJE-10-0498. Epub 2010 Jun 1. No abstract available.

PMID:
20516207
7.

Repeated colonoscopic screening of patients with acromegaly: 15-year experience identifies those at risk of new colonic neoplasia and allows for effective screening guidelines.

Dworakowska D, Gueorguiev M, Kelly P, Monson JP, Besser GM, Chew SL, Akker SA, Drake WM, Fairclough PD, Grossman AB, Jenkins PJ.

Eur J Endocrinol. 2010 Jul;163(1):21-8. doi: 10.1530/EJE-09-1080. Epub 2010 Apr 30.

PMID:
20435617
8.

Diagnosis, management and therapeutic outcome in prepubertal Cushing's disease.

Dias RP, Kumaran A, Chan LF, Martin L, Afshar F, Matson M, Plowman PN, Monson JP, Besser GM, Grossman AB, Savage MO, Storr HL.

Eur J Endocrinol. 2010 Mar;162(3):603-9. doi: 10.1530/EJE-09-0509. Epub 2009 Dec 1.

PMID:
19952125
9.

Gamma knife radiosurgery: a safe and effective salvage treatment for pituitary tumours not controlled despite conventional radiotherapy.

Swords FM, Monson JP, Besser GM, Chew SL, Drake WM, Grossman AB, Plowman PN.

Eur J Endocrinol. 2009 Dec;161(6):819-28. doi: 10.1530/EJE-09-0493. Epub 2009 Sep 22.

PMID:
19773368
10.

The prevalence and characteristic features of cyclicity and variability in Cushing's disease.

Alexandraki KI, Kaltsas GA, Isidori AM, Akker SA, Drake WM, Chew SL, Monson JP, Besser GM, Grossman AB.

Eur J Endocrinol. 2009 Jun;160(6):1011-8. doi: 10.1530/EJE-09-0046. Epub 2009 Mar 16.

PMID:
19289537
11.

Role of fasting plasma glucose, glycated haemoglobin and homeostatic model assessment in the detection of glucose intolerance in adult hypopituitary patients during growth hormone replacement therapy.

Colson A, Walker D, Besser GM, Grossman AB, Chew SL, Jenkins PJ, Drake WM, Monson JP.

Horm Res. 2008;69(2):83-8. Epub 2007 Dec 5.

PMID:
18059088
12.

Safety of GH replacement in hypopituitary patients with nonirradiated pituitary and peripituitary tumours.

Chung TT, Evanson J, Walker D, Akker SA, Besser GM, Monson JP, Grossman AB, Drake WM.

Clin Endocrinol (Oxf). 2008 Jun;68(6):965-9. Epub 2007 Nov 19.

PMID:
18031317
13.

Abnormal puberty in paediatric Cushing's disease: relationship with adrenal androgen, sex hormone binding globulin and gonadotrophin concentrations.

Dupuis CC, Storr HL, Perry LA, Ho JT, Ahmed L, Ong KK, Dunger DB, Monson JP, Grossman AB, Besser GM, Savage MO.

Clin Endocrinol (Oxf). 2007 Jun;66(6):838-43. Epub 2007 Apr 15.

PMID:
17437509
14.

Long-term anterior pituitary function in patients with paediatric Cushing's disease treated with pituitary radiotherapy.

Chan LF, Storr HL, Plowman PN, Perry LA, Besser GM, Grossman AB, Savage MO.

Eur J Endocrinol. 2007 Apr;156(4):477-82.

PMID:
17389463
15.
16.

Parafibromin mutations in hereditary hyperparathyroidism syndromes and parathyroid tumours.

Bradley KJ, Cavaco BM, Bowl MR, Harding B, Cranston T, Fratter C, Besser GM, Conceição Pereira M, Davie MW, Dudley N, Leite V, Sadler GP, Seller A, Thakker RV.

Clin Endocrinol (Oxf). 2006 Mar;64(3):299-306.

PMID:
16487440
17.

The management of differentiated thyroid cancer using 123I for imaging to assess the need for 131I therapy.

Ali N, Sebastian C, Foley RR, Murray I, Canizales AL, Jenkins PJ, Drake WM, Plowman PN, Besser GM, Chew SL, Grossman AB, Monson JP, Britton KE.

Nucl Med Commun. 2006 Feb;27(2):165-9.

PMID:
16404230
18.

The ectopic adrenocorticotropin syndrome: clinical features, diagnosis, management, and long-term follow-up.

Isidori AM, Kaltsas GA, Pozza C, Frajese V, Newell-Price J, Reznek RH, Jenkins PJ, Monson JP, Grossman AB, Besser GM.

J Clin Endocrinol Metab. 2006 Feb;91(2):371-7. Epub 2005 Nov 22.

PMID:
16303835
19.

Tumour surveillance imaging in patients with extrapituitary tumours receiving growth hormone replacement.

Chung TT, Drake WM, Evanson J, Walker D, Plowman PN, Chew SL, Grossman AB, Besser GM, Monson JP.

Clin Endocrinol (Oxf). 2005 Sep;63(3):274-9.

PMID:
16117814
20.

Predictors and rates of treatment-resistant tumor growth in acromegaly.

Besser GM, Burman P, Daly AF.

Eur J Endocrinol. 2005 Aug;153(2):187-93. Review.

21.

Factors influencing cure by transsphenoidal selective adenomectomy in paediatric Cushing's disease.

Storr HL, Afshar F, Matson M, Sabin I, Davies KM, Evanson J, Plowman PN, Besser GM, Monson JP, Grossman AB, Savage MO.

Eur J Endocrinol. 2005 Jun;152(6):825-33.

PMID:
15941921
22.

Clinical and biochemical characteristics of adrenocorticotropin-secreting macroadenomas.

Woo YS, Isidori AM, Wat WZ, Kaltsas GA, Afshar F, Sabin I, Jenkins PJ, Monson JP, Besser GM, Grossman AB.

J Clin Endocrinol Metab. 2005 Aug;90(8):4963-9. Epub 2005 May 10.

PMID:
15886242
23.

Final adult height and body mass index after cure of paediatric Cushing's disease.

Davies JH, Storr HL, Davies K, Monson JP, Besser GM, Afshar F, Plowman PN, Grossman AB, Savage MO.

Clin Endocrinol (Oxf). 2005 Apr;62(4):466-72.

PMID:
15807878
24.

Dramatic response of malignant craniopharyngioma to cis-platin-based chemotherapy. Should craniopharyngioma be considered as a suprasellar 'germ cell' tumour?

Plowman PN, Besser GM, Shipley J, Summersgill B, Geddes J, Afshar F.

Br J Neurosurg. 2004 Oct;18(5):500-5.

PMID:
15799153
25.

Disease activity in acromegaly may be assessed 6 weeks after discontinuation of pegvisomant.

Drake WM, Loureiro RA, Parkinson C, Monson JP, Besser GM, Trainer PJ.

Eur J Endocrinol. 2005 Jan;152(1):47-51.

PMID:
15762186
26.

Predicting therapeutic response and degree of pituitary tumour shrinkage during treatment of acromegaly with octreotide LAR.

Jenkins PJ, Emery M, Howling SJ, Evanson J, Besser GM, Monson JP.

Horm Res. 2004;62(5):227-32. Epub 2004 Oct 11.

PMID:
15477693
27.

Prepubertal Cushing's disease is more common in males, but there is no increase in severity at diagnosis.

Storr HL, Isidori AM, Monson JP, Besser GM, Grossman AB, Savage MO.

J Clin Endocrinol Metab. 2004 Aug;89(8):3818-20.

PMID:
15292311
28.

Diagnostic performance of CT versus MR in detecting aldosterone-producing adenoma in primary hyperaldosteronism (Conn's syndrome).

Lingam RK, Sohaib SA, Rockall AG, Isidori AM, Chew S, Monson JP, Grossman A, Besser GM, Reznek RH.

Eur Radiol. 2004 Oct;14(10):1787-92. Epub 2004 Jul 6.

PMID:
15241622
29.

Secondary forms of polycystic ovary syndrome.

Kaltsas GA, Isidori AM, Besser GM, Grossman AB.

Trends Endocrinol Metab. 2004 Jul;15(5):204-10. Review.

PMID:
15223049
30.

The diagnosis and medical management of advanced neuroendocrine tumors.

Kaltsas GA, Besser GM, Grossman AB.

Endocr Rev. 2004 Jun;25(3):458-511. Review.

PMID:
15180952
31.

Modulation of cortisol metabolism during treatment of acromegaly is independent of body composition and insulin sensitivity.

Frajese GV, Taylor NF, Jenkins PJ, Besser GM, Monson JP.

Horm Res. 2004;61(5):246-51. Epub 2004 Mar 2.

PMID:
15004437
32.

Successful treatment of childhood-onset Cushing's disease is associated with persistent reduction in growth hormone secretion.

Carroll PV, Monson JP, Grossman AB, Besser GM, Plowman PN, Afshar F, Savage MO.

Clin Endocrinol (Oxf). 2004 Feb;60(2):169-74.

PMID:
14725677
33.

Computed tomography assessment of fat distribution in male and female patients with Cushing's syndrome.

Rockall AG, Sohaib SA, Evans D, Kaltsas G, Isidori AM, Monson JP, Besser GM, Grossman AB, Reznek RH.

Eur J Endocrinol. 2003 Dec;149(6):561-7.

PMID:
14640998
34.

Hepatic steatosis in Cushing's syndrome: a radiological assessment using computed tomography.

Rockall AG, Sohaib SA, Evans D, Kaltsas G, Isidori AM, Monson JP, Besser GM, Grossman AB, Reznek RH.

Eur J Endocrinol. 2003 Dec;149(6):543-8.

PMID:
14640995
35.

Insulin sensitivity and glucose tolerance improve in patients with acromegaly converted from depot octreotide to pegvisomant.

Drake WM, Rowles SV, Roberts ME, Fode FK, Besser GM, Monson JP, Trainer PJ.

Eur J Endocrinol. 2003 Dec;149(6):521-7.

PMID:
14640992
36.

Stereotactic radiosurgery XVI: a treatment for previously irradiated pituitary adenomas.

Swords FM, Allan CA, Plowman PN, Sibtain A, Evanson J, Chew SL, Grossman AB, Besser GM, Monson JP.

J Clin Endocrinol Metab. 2003 Nov;88(11):5334-40.

PMID:
14602770
37.

Discriminatory value of the low-dose dexamethasone suppression test in establishing the diagnosis and differential diagnosis of Cushing's syndrome.

Isidori AM, Kaltsas GA, Mohammed S, Morris DG, Jenkins P, Chew SL, Monson JP, Besser GM, Grossman AB.

J Clin Endocrinol Metab. 2003 Nov;88(11):5299-306.

PMID:
14602765
38.

The value of the low-dose dexamethasone suppression test in the differential diagnosis of hyperandrogenism in women.

Kaltsas GA, Isidori AM, Kola BP, Skelly RH, Chew SL, Jenkins PJ, Monson JP, Grossman AB, Besser GM.

J Clin Endocrinol Metab. 2003 Jun;88(6):2634-43.

PMID:
12788867
39.

The effect of growth hormone replacement therapy on adrenal androgen secretion in adult onset hypopituitarism.

Isidori AM, Kaltsas GA, Perry L, Burrin JM, Besser GM, Monson JP.

Clin Endocrinol (Oxf). 2003 May;58(5):601-11.

PMID:
12699442
40.

The relationship between pituitary tumour transforming gene (PTTG) expression and in vitro hormone and vascular endothelial growth factor (VEGF) secretion from human pituitary adenomas.

Hunter JA, Skelly RH, Aylwin SJ, Geddes JF, Evanson J, Besser GM, Monson JP, Burrin JM.

Eur J Endocrinol. 2003 Feb;148(2):203-11.

PMID:
12590639
41.

Clinical and endocrine responses to pituitary radiotherapy in pediatric Cushing's disease: an effective second-line treatment.

Storr HL, Plowman PN, Carroll PV, François I, Krassas GE, Afshar F, Besser GM, Grossman AB, Savage MO.

J Clin Endocrinol Metab. 2003 Jan;88(1):34-7.

PMID:
12519825
42.

Neurosurgical treatment of Nelson's syndrome.

Kelly PA, Samandouras G, Grossman AB, Afshar F, Besser GM, Jenkins PJ.

J Clin Endocrinol Metab. 2002 Dec;87(12):5465-9.

PMID:
12466338
43.

HRPT2, encoding parafibromin, is mutated in hyperparathyroidism-jaw tumor syndrome.

Carpten JD, Robbins CM, Villablanca A, Forsberg L, Presciuttini S, Bailey-Wilson J, Simonds WF, Gillanders EM, Kennedy AM, Chen JD, Agarwal SK, Sood R, Jones MP, Moses TY, Haven C, Petillo D, Leotlela PD, Harding B, Cameron D, Pannett AA, Höög A, Heath H 3rd, James-Newton LA, Robinson B, Zarbo RJ, Cavaco BM, Wassif W, Perrier ND, Rosen IB, Kristoffersson U, Turnpenny PD, Farnebo LO, Besser GM, Jackson CE, Morreau H, Trent JM, Thakker RV, Marx SJ, Teh BT, Larsson C, Hobbs MR.

Nat Genet. 2002 Dec;32(4):676-80. Epub 2002 Nov 18.

PMID:
12434154
44.

Pancreatic lesions in von Hippel-Lindau disease.

Mukhopadhyay B, Sahdev A, Monson JP, Besser GM, Reznek RH, Chew SL.

Clin Endocrinol (Oxf). 2002 Nov;57(5):603-8.

PMID:
12390333
45.

Growth in disorders of adrenal hyperfunction.

Savage MO, Scommegna S, Carroll PV, Ho JT, Monson JP, Besser GM, Grossman AB.

Horm Res. 2002;58 Suppl 1:39-43. Review.

PMID:
12373013
46.

Suprasellar germ cell tumours: specific problems and the evolution of optimal management with a combined chemoradiotherapy regimen.

Janmohamed S, Grossman AB, Metcalfe K, Lowe DG, Wood DF, Chew SL, Monson JP, Besser GM, Plowman PN.

Clin Endocrinol (Oxf). 2002 Oct;57(4):487-500.

PMID:
12354131
47.

Treatment of advanced neuroendocrine tumours using combination chemotherapy with lomustine and 5-fluorouracil.

Kaltsas GA, Mukherjee JJ, Isidori A, Kola B, Plowman PN, Monson JP, Grossman AB, Besser GM.

Clin Endocrinol (Oxf). 2002 Aug;57(2):169-83. Review.

PMID:
12153595
48.

Growth hormone replacement does not increase serum prostate-specific antigen in hypopituitary men over 50 years.

le Roux CW, Jenkins PJ, Chew SL, Camacho-Hübner C, Grossman AB, Besser GM, Monson JP.

Eur J Endocrinol. 2002 Jul;147(1):59-63.

PMID:
12088920
49.

Serum lipoprotein changes following IGF-I normalization using a growth hormone receptor antagonist in acromegaly.

Parkinson C, Drake WM, Wieringa G, Yates AP, Besser GM, Trainer PJ.

Clin Endocrinol (Oxf). 2002 Mar;56(3):303-11.

PMID:
11940041
50.

Supplemental Content

Loading ...
Support Center